Corrigendum: Management of metastatic endometrial cancer: physicians’ choices beyond the first line after approval of checkpoint inhibitors

• Francesca Arezzo,
• Francesca Arezzo,
• Gaia Giannone,
• Daniele Castaldo,
• Giulia Scotto,
• Valentina Tuninetti,
• Margherita Turinetto,
• Michele Bartoletti,
• Serafina Mammoliti,
• Grazia Artioli,
• Giorgia Mangili,
• Vanda Salutari,
• Domenica Lorusso,
• Gennaro Cormio,
• Gennaro Cormio,
• Vera Loizzi,
• Vera Loizzi,
• Claudio Zamagni,
• Antonella Savarese,
• Massimo Di Maio,
• Graziana Ronzino,
• Carmela Pisano,
• Sandro Pignata,
• Giorgio Valabrega

Affiliations

Francesca Arezzo

Gynecologic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy

Francesca Arezzo

Department of Precision and Regenerative Medicine – Ionian Area, University of Bari “Aldo Moro”, Bari, Italy

Gaia Giannone

Department of Surgery and Cancer, Imperial College London, London, United Kingdom

Daniele Castaldo

Segreteria Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO) Group, Naples, Italy

Giulia Scotto

Department of Oncology, University of Turin, Turin, Italy

Valentina Tuninetti

Department of Oncology, Mauriziano Hospital, University of Turin, Turin, Italy

Margherita Turinetto

Department of Oncology, University of Turin, Turin, Italy

Michele Bartoletti

Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy

Serafina Mammoliti

Ospedale Policlinico San Martino - Department of Medical Oncology, IRCCS, Genoa, Italy

Grazia Artioli

Oncologia Medica, Unità locale socio sanitaria n2 (ULSS2) Marca Trevigiana, Treviso, Italy

Giorgia Mangili

0Obstet-Gynecol Department, San Raffaele Scientific Institute, IRCCS, Milan, Italy

Vanda Salutari

1Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy

Domenica Lorusso

2Department of Life Science and Public Health, Catholic University of Sacred Heart Largo Agostino Gemelli, and Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy

Gennaro Cormio

Gynecologic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy

Gennaro Cormio

3Interdisciplinar Department of Medicine, University of Bari “Aldo Moro”, Bari, Italy

Vera Loizzi

Gynecologic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy

Vera Loizzi

3Interdisciplinar Department of Medicine, University of Bari “Aldo Moro”, Bari, Italy

Claudio Zamagni

4Azienda Ospedaliero-universitaria di Bologna, IRCCS, Bologna, Italy

Antonella Savarese

5Department of Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy

Massimo Di Maio

Department of Oncology, Mauriziano Hospital, University of Turin, Turin, Italy

Graziana Ronzino

6Department of Oncology, Ospedale “Vito Fazzi”, Lecce, Italy

Carmela Pisano

7Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Napoli, Naples, Italy

Sandro Pignata

7Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Napoli, Naples, Italy

Giorgio Valabrega

Department of Oncology, Mauriziano Hospital, University of Turin, Turin, Italy